Cargando…

Comment on: Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis

Detalles Bibliográficos
Autores principales:	WU, Yin, NEGERI, Zelalem, BENEDETTI, Andrea, THOMBS, Brett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish League Against Rheumatism 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788642/ https://www.ncbi.nlm.nih.gov/pubmed/33458674 http://dx.doi.org/10.46497/ArchRheumatol.2020.7920

Ejemplares similares

Mental health before and during the pandemic in people with systemic sclerosis
por: Henry, Richard S, et al.
Publicado: (2022)

Response to the Letter to the Editor: Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis
por: MARCH, Christine, et al.
Publicado: (2020)

Results from a living systematic review of the prevalence of mood and anxiety disorders and factors associated with symptoms in systemic sclerosis
por: Nassar, Elsa-Lynn, et al.
Publicado: (2023)

An Assessment of the Measurement Equivalence of English and French Versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis
por: Delisle, Vanessa C., et al.
Publicado: (2014)

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
por: Levis, Brooke, et al.
Publicado: (2019)

Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Fiddes, Barnaby, et al.
Publicado: (2014)

Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study
por: Wu, Yin, et al.
Publicado: (2021)

Comparison of depression prevalence estimates in meta-analyses based on screening tools and rating scales versus diagnostic interviews: a meta-research review
por: Levis, Brooke, et al.
Publicado: (2019)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018)

Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
por: Fischer, Felix, et al.
Publicado: (2023)

Critical Comment on Depression in Main Caregivers of Dementia Patients: Prevalence and Predictors
por: Saini, Radha, et al.
Publicado: (2018)

Assessment of the Prevalence and Trajectory of Depressive Symptoms by Sexual Orientation During Physician Training
por: Patel, Tejal H., et al.
Publicado: (2022)

Comment: Prevalence of Hypercholesterolemia and Awareness of Risk Factors, Prevention and Management Among Adults [Letter]
por: Nugroho, Heru Santoso Wahito, et al.
Publicado: (2023)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

How prevalent are depression and anxiety symptoms in hypothyroidism?
por: Praharaj, Samir Kumar
Publicado: (2016)

Sexual Activity and Impairment in Women with Systemic Sclerosis Compared to Women from a General Population Sample
por: Levis, Brooke, et al.
Publicado: (2012)

Comment on “Proposal for a modified classification of isolated zygomatic arch fractures”
por: Frosolini, Andrea, et al.
Publicado: (2023)

Comments on the review article ‘Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades’
por: Berg‐Hansen, P., et al.
Publicado: (2015)

Comment on “Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia”
por: Badri, Talel
Publicado: (2018)

Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
por: Thombs, Brett D., et al.
Publicado: (2020)

Reply to “How prevalent are depression and anxiety symptoms in hypothyroidism?”
por: Bathla, Manish, et al.
Publicado: (2016)

Selective cutoff reporting in studies of the accuracy of the Patient Health Questionnaire‐9 and Edinburgh Postnatal Depression Scale: Comparison of results based on published cutoffs versus all cutoffs using individual participant data meta‐analysis
por: Neupane, Dipika, et al.
Publicado: (2021)

Revisiting Gender Differences in Somatic Symptoms of Depression: Much Ado about Nothing?
por: Delisle, Vanessa C., et al.
Publicado: (2012)

Response to: Comment on “Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia”
por: Toukabri, Nourchène, et al.
Publicado: (2018)

A Comment on “Prevalence and Factors Associated with Depression among Clinically Stable People Living with HIV/AIDS on Antiretroviral Therapy”
por: Basu, Saurav
Publicado: (2018)

Comment on "Encapsulating Peritoneal Sclerosis in a kidney transplant recipient: Case Report"
por: Li Cavoli, Gioacchino, et al.
Publicado: (2021)

The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis
por: Gariepy, Genevieve, et al.
Publicado: (2015)

Bright light therapy for depressive symptoms in hospitalized cardiac patients: A randomized controlled pilot trial
por: Eisenberg, Mark J., et al.
Publicado: (2020)

Sociodemographic and Disease Correlates of Body Image Distress among Patients with Systemic Sclerosis
por: Jewett, Lisa R., et al.
Publicado: (2012)

Comments on “Prevalence and Predictors of Abuse in Elderly Patients with Depression at a Tertiary Care Centre in Saurashtra, India”
por: Rohilla, Jitendra, et al.
Publicado: (2019)

Comment on ‘Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis’
por: Zhang, Fan, et al.
Publicado: (2022)

Comment on ‘Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis’
por: Zhang, Xiao‐Ming, et al.
Publicado: (2022)

Correspondence on population health surveys and screening tools for depressive disorders: aims and uses by Arias de la Torre et al
por: Fischer, Felix, et al.
Publicado: (2023)

Authors’ Response to Comments on “Prevalence and Factors Associated with Depression among Clinically Stable People Living with HIV/AIDS on Antiretroviral Therapy
por: Algoodkar, Sharanabasappa Ambaraya, et al.
Publicado: (2018)

Prevalence of depressive symptoms due to COVID-19 and associated factors among healthcare workers in Southern Ethiopia
por: Wayessa, Zelalem Jabessa, et al.
Publicado: (2021)

Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study
por: Wu, Yin, et al.
Publicado: (2020)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

The hippocampus and executive functions in depression: Comments on the article
por: Chandrasekaran, Vigneshvar, et al.
Publicado: (2018)

Comment on ‘The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy’
por: Grzegorzewska, Agata M., et al.
Publicado: (2023)

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study
por: Wojeck, Robyn K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nqfsol0kefbjn36qjcib7mfva5